LifePoint Hospitals' CEO Discusses Q1 2012 Results - Earnings Call Transcript

LifePoint Hospitals, Inc. (LPNT)

Q1 2012 Earnings Call

April 27, 2012 10:00 AM ET

Executives

William Carpenter – Chairman and CEO

Jeffrey Sherman – EVP and CFO

David Dill – President and COO

Analysts

Adam Feinstein – Barclays Capital

Ralph Giacobbe – Credit Suisse

Frank Morgan – RBC Capital Markets

Gary Lieberman – Wells Fargo

AJ Rice – UBS

Kevin Fischbeck – Bank of America/Merrill Lynch

Gary Taylor – Citigroup

Thomas Gallucci – Lazard

Whit Mayo – Robert W Baird

Darren Lehrich – Deutsche Bank

Presentation

Operator

Ladies and gentlemen, thank you for standing by. Welcome to the LifePoint Hospital’s First Quarter 2012 Earnings Conference Call. (Operator Instructions) On today’s call LifePoint will be making forward-looking statements based upon management’s current expectations. Numerous factors could cause LifePoint’s results to defer from these expectations and LifePoint has outlined these factors in its filings with the SEC. The company encourages you to review these filings. LifePoint also asks that you please review the cautionary language under the caption Important Legal Information in the company’s press release issued this morning.

The company undertakes no obligation to update or make any other forward-looking statements whether as a result of new information, future events or otherwise. Also please visit LifePoint’s website for links to various information and filings. (Operator Instructions) As a reminder, this conference is being recorded Friday, April 27, 2012. I would now like to turn the conference over to William Carpenter, Chairman and Chief Executive Officer. Please go ahead, sir.

If you liked this article you might like

Downgrade Won't Cure What Ails LifePoint Health

Downgrade Won't Cure What Ails LifePoint Health

Downgrade Won't Cure What Ails LifePoint Health

Why More Limbo on Healthcare Reform Is Bad News for Hospital Stocks

Hospitals Take Another Hit From Latest Senate Health Plan

Wall Street Weighs What's Next on Healthcare